Subsidy Information and Financing Scheme MAFFingolimod Capsule 0.25 mg, 0.5 mg Treatment of adults and children with relapsing-remitting multiple sclerosis.
Drug Guidance for Subsidy 04/01/2022 Disease-modifying therapies for treating multiple sclerosis The Ministry of Health’s Drug Advisory Committee has recommended: Fingolimod 0.25 mg and 0.5 ... See all × 04/01/2022 Disease-modifying therapies for treating multiple sclerosis The Ministry of Health’s Drug Advisory Committee has recommended: Fingolimod 0.25 mg and 0.5 mg capsules for treating adults and children with relapsing-remitting multiple sclerosis, and Siponimod 0.25 mg and 2 mg tablets for treating adults with secondary progressive multiple sclerosis with active disease evidenced by relapses or imaging features of inflammatory activity. Subsidy status RFingolimod 0.25 mg and 0.5 mg capsules and siponimod 0.25 mg and 2 mg tablets are recommended for inclusion on the Medication Assistance Fund (MAF) for the abovementioned indications. NRMAF assistance does not apply to any formulations or strengths of alemtuzumab, cladribine, dimethyl fumarate, interferon beta-1a, natalizumab, ofatumumab or teriflunomide for treating adults or children with any form of multiple sclerosis.
Post Marketing Information PEM 14/08/2024 Gilenya® 0.25 mg and 0.5 mg hard capsules (fingolimod): Physician’s Checklist: Summary of recommendations PEM 29/06/2022 Fingolimod Accord: Prescriber’s Checklist: Summary of Recommendations PMG 14/08/2024 Understanding your or your child's treatment with GILENYA® (Fingolimod): A guide for people with relapsing-remitting MS PMG 29/06/2022 Fingolimod Accord: Important things for Patients, Parents and Caregivers to remember about Fingolimod Accord treatment PAC 14/08/2024 Gilenya® (fingolimod): Pregnancy-Specific Patient Reminder Card PAC 29/06/2022 Fingolimod Accord: Pregnancy-Specific Patient Reminder Card
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Capsule 0.5 mg National University Hospital Tan Tock Seng Hospital
ORAL Select a brand starting with the letter: F G FINCORD CAPSULES 0.5 MG [SIN16528P] GILENYA CAPSULE 0.25MG [SIN15761P] GILENYA CAPSULE 0.5MG [SIN14153P]